United States · Funded startup

Who invested in CRISPR THERAPEUTICS

One round we have observed, with the 3 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

BiotechHealthcarePharma

Raised 8 months ago

Funding summaryUpdated 26 Oct 2026

$550Mraised across 1 round since 2026, from 1 source

Latest round
Debt, $550MMar 2026
Investors
3
See who backed them

The rounds

  1. Mar 2026

Founders and team

From CRISPR THERAPEUTICS's own website: 3 on the team.

  • Megan Wherry MennerHead of Human Resources
  • Stephen KennedyHead of Technical Operations
  • James R. KasingerGeneral Counsel and Secretary

Everyone who backed them

Versant VenturesVC firm1round
Franklin TempletonPrivate equity1round

Missing a round, or an investor who was in one? Tell us.

Quick answers about CRISPR THERAPEUTICS

Who invested in CRISPR THERAPEUTICS?

CRISPR THERAPEUTICS's investors include New Enterprise Associates, Versant Ventures and Franklin Templeton.

How much has CRISPR THERAPEUTICS raised?

CRISPR THERAPEUTICS has raised $550M across 1 round since 2026.

When did CRISPR THERAPEUTICS last raise?

CRISPR THERAPEUTICS's most recent round was a Debt of $550M in Mar 2026.

What was CRISPR THERAPEUTICS's biggest round?

Its most recent round, $550M in Mar 2026, is also its largest on record.

Who backed CRISPR THERAPEUTICS first?

CRISPR THERAPEUTICS's first round on record, in Mar 2026, was backed by New Enterprise Associates, Versant Ventures and Franklin Templeton.

What stage is CRISPR THERAPEUTICS at?

CRISPR THERAPEUTICS's latest named round is a Debt, in Mar 2026.

Where is CRISPR THERAPEUTICS based?

CRISPR THERAPEUTICS is based in the United States.

Companies like CRISPR THERAPEUTICS

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.